| INOVIO PHARMACEUTICAL INC |
| USA |
| Gesundheit |
| US45773H4092 / A400EJ |
| GBM (Frankfurt) / INO (NASDAQ) |
| FRA:GBM, ETR:GBM, GBM:GR, NASDAQ:INO |
| - |
| https://inovio.com/ |
|
Inovio Pharmaceuticals, Inc. is a biotechnology co..
>Volltext.. |
| 139.03 Mio. EUR |
| 104.25 Mio. EUR |
| 0.16 Mio. EUR |
| -74.03 Mio. EUR |
| -92.3 Mio. EUR |
| -2.21 EUR |
| 8.56 Mio. EUR |
| 31.22 Mio. EUR |
| -75.93 Mio. EUR |
| 0.73 |
| -14.95% |
| 9.14% |
| - |
| - |
| - |
| - |
| INOVIO |
| 21.12.25 |
|